HomeCompareNPRRF vs O

NPRRF vs O: Dividend Comparison 2026

NPRRF yields 1.90% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 O wins by $11.8K in total portfolio value· pulled ahead in Year 3
10 years
NPRRF
NPRRF
● Live price
1.90%
Share price
$9.96
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$214.67
Full NPRRF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.15
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,102.74
Full O calculator →

Portfolio growth — NPRRF vs O

📍 O pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPRRFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPRRF + O cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPRRF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPRRF
Annual income on $10K today (after 15% tax)
$161.38/yr
After 10yr DRIP, annual income (after tax)
$182.47/yr
O
Annual income on $10K today (after 15% tax)
$449.12/yr
After 10yr DRIP, annual income (after tax)
$4,337.33/yr
At 15% tax rate, O beats the other by $4,154.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPRRF + O for your $10,000?

NPRRF: 50%O: 50%
100% O50/50100% NPRRF
Portfolio after 10yr
$28.3K
Annual income
$2,658.71/yr
Blended yield
9.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

NPRRF
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.7% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPRRF buys
0
O buys
0
No recent congressional trades found for NPRRF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPRRFO
Forward yield1.90%5.28%
Annual dividend / share$0.19$3.23
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1%
Portfolio after 10y$22.5K$34.2K
Annual income after 10y$214.67$5,102.74
Total dividends collected$2.0K$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: NPRRF vs O ($10,000, DRIP)

YearNPRRF PortfolioNPRRF Income/yrO PortfolioO Income/yrGap
1$10,890$189.86$10,818$608.16+$72.00NPRRF
2$11,845$193.23$11,787$741.68+$58.00NPRRF
3← crossover$12,871$196.43$12,946$911.00$75.00O
4$13,971$199.48$14,345$1,127.94$374.00O
5$15,152$202.37$16,056$1,409.05$904.00O
6$16,418$205.11$18,171$1,777.83$1.8KO
7$17,774$207.70$20,820$2,268.21$3.0KO
8$19,229$210.16$24,188$2,929.90$5.0KO
9$20,787$212.48$28,533$3,837.11$7.7KO
10$22,457$214.67$34,235$5,102.74$11.8KO

NPRRF vs O: Complete Analysis 2026

NPRRFStock

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. The company's Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, syringes, and cartridges; glass tubes; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Full NPRRF Calculator →

OREIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this NPRRF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPRRF vs SCHDNPRRF vs JEPINPRRF vs KONPRRF vs MAINNPRRF vs STAGNPRRF vs ADCNPRRF vs NNNNPRRF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.